MILESTONE SCIENTIFIC INC. (MLSS) — SEC Financial Statements & Analysis

MILESTONE SCIENTIFIC INC. (MLSS) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. MILESTONE SCIENTIFIC INC. trades on NYSE as: MLSS. MILESTONE SCIENTIFIC INC. (MLSS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, MILESTONE SCIENTIFIC INC. carries a market cap of $29.80M, a P/E ratio of -7.19x, a P/B ratio of 8.59x, a P/S ratio of 3.16x, an enterprise value of $28.25M, and an EV/EBITDA multiple of -7.02x. On profitability, it posts a gross margin of 70.23%, an operating margin of -43.56%, a net margin of -43.98%, a Return on Equity (ROE) of -121.67%, a Return on Assets (ROA) of -50.54%, and a Return on Invested Capital (ROIC) of -157.37%. Per share, it reports EPS of $-0.04, diluted EPS of $-0.04, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 3.72% year-over-year, net income growth of -40.59% year-over-year, and EPS growth of -47.65% year-over-year. On the balance sheet, it maintains a current ratio of 1.85x, a quick ratio of 1.00x, working capital of $3.72M, a debt-to-equity ratio of 1.41x, a debt ratio of 0.58, an interest coverage ratio of -92.45x, free cash flow of $-657.76K (TTM), and net debt of $-1.55M. Figures sourced from SEC EDGAR.

Market Cap

$29.80M

P/E TTM

-7.19x

EPS TTM

$-0.04

P/B TTM

8.59x

ROE TTM

-121.67%

ROA TTM

-50.54%

Debt To Equity

1.41x

Free Cash Flow TTM

$-657.76K

Net Revenue TTM Growth 1Y

3.72%

Data as of 2026-06-30 · Source: SEC EDGAR